Page last updated: 2024-08-26

selenium and oridonin

selenium has been researched along with oridonin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, H; Cai, J; Chen, ZW; Jiang, J; Jin, H; Pi, J; Yang, F; Yang, P	1

Other Studies

1 other study(ies) available for selenium and oridonin

Article	Year
GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways. Drug delivery, 2017, Volume: 24, Issue:1 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Diterpenes, Kaurane; Drug Carriers; Drug Liberation; ErbB Receptors; Humans; Interleukin-2; MAP Kinase Signaling System; Mice; Nanoparticles; Peptides; Platelet Endothelial Cell Adhesion Molecule-1; Reactive Oxygen Species; Selenium; Tumor Necrosis Factor-alpha	2017

Article

Year

GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.

Drug delivery, 2017, Volume: 24, Issue:1

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Diterpenes, Kaurane; Drug Carriers; Drug Liberation; ErbB Receptors; Humans; Interleukin-2; MAP Kinase Signaling System; Mice; Nanoparticles; Peptides; Platelet Endothelial Cell Adhesion Molecule-1; Reactive Oxygen Species; Selenium; Tumor Necrosis Factor-alpha

2017